Sepsis-related acute kidney injury: a protective effect of drotrecogin alfa (activated) treatment?
dc.contributor.author | Van Doorn, K. J. | en_US |
dc.contributor.author | Spapen, H. | en_US |
dc.contributor.author | Geers, C. | en_US |
dc.contributor.author | Diltoer, M. | en_US |
dc.contributor.author | Shabana, W. | en_US |
dc.date.accessioned | 2010-04-01T14:55:35Z | |
dc.date.available | 2010-04-01T14:55:35Z | |
dc.date.issued | 2008-10 | en_US |
dc.identifier.citation | VAN DOORN, K. J.; SPAPEN, H.; GEERS, C.; DILTOER, M.; SHABANA, W. (2008). "Sepsis-related acute kidney injury: a protective effect of drotrecogin alfa (activated) treatment?." Acta Anaesthesiologica Scandinavica 52(9): 1259-1264. <http://hdl.handle.net/2027.42/65383> | en_US |
dc.identifier.issn | 0001-5172 | en_US |
dc.identifier.issn | 1399-6576 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65383 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18823466&dopt=citation | en_US |
dc.description.abstract | Drotrecogin alfa activated (DrotAA) is licensed for treatment of patients with severe sepsis and organ failure. Among the latter, acute kidney injury (AKI), defined as the persistence of oligo-anuria following adequate resuscitation, is one of the most apprehended. We conducted a prospective, observational, and controlled study to test the hypothesis that DrotAA beneficially affected the evolution and outcome of AKI, complicating acute sepsis-induced cardiopulmonary failure. Methods : Forty-six patients were studied. Thirty subjects received standard treatment for sepsis without DrotAA. In the remaining 16 patients, DrotAA was added as a continuous infusion of 24 Μg/kg/h for 96 h. Results : Mean age, causes of sepsis, and severity/organ failure scores were comparable between patients treated with or without DrotAA. Mortality at 28 days was high and comparable between both treatment groups (56% vs. 69%, DrotAA vs. no DrotAA; P =0.5). When oligo-anuria was present at the start of the study, it persisted during treatment in all patients, with no significant difference between groups. Both treatment groups presented with baseline mean daily fractional excretion of sodium values >2% that remained high during the observation period, regardless of whether DrotAA was given or not. Kidney histology showed a preserved renal architecture with tubular necrosis in all specimens. Similar glomerular, tubulo-interstitial, and vascular alterations were present in both treatment groups. Conclusion : In this small cohort of patients with severe sepsis who received adjuvant DrotAA treatment, no effect on urine output, tubular function, or mortality could be demonstrated. | en_US |
dc.format.extent | 110374 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Journal compilation © 2008 The Acta Anaesthesiologica Scandinavica Foundation | en_US |
dc.title | Sepsis-related acute kidney injury: a protective effect of drotrecogin alfa (activated) treatment? | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Surgery and Anesthesiology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan Health System, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Critical Care and Nephrology, St Vincentius Hospital, Antwerp, Belgium , Departments of | en_US |
dc.contributor.affiliationother | Critical Care , | en_US |
dc.contributor.affiliationother | Pathology , | en_US |
dc.contributor.affiliationother | Critical Care, University Hospital, Vrije Universiteit Brussels, Brussels, Belgium and | en_US |
dc.identifier.pmid | 18823466 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65383/1/j.1399-6576.2008.01738.x.pdf | |
dc.identifier.doi | 10.1111/j.1399-6576.2008.01738.x | en_US |
dc.identifier.source | Acta Anaesthesiologica Scandinavica | en_US |
dc.identifier.citedreference | Singh S, Evans T. Organ dysfunction during sepsis. Intensive Care Med 2006 ; 32 : 349 – 60. | en_US |
dc.identifier.citedreference | Yegenaga I, Hoste E, Van Biesen W, Vanholder R, Benoit D, Kantarci G, Dhondt A, Colardyn F, Lameire N. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome : results of a prospective study. Am J Kidney Dis 2004 ; 43 : 817 – 24. | en_US |
dc.identifier.citedreference | Kikeri D, Pennell JP, Hwang KH, Jacob AI, Richman AV, Bourgoignie JJ. Endotoxemic acute renal failure in awake rats. Am J Physiol 1986 ; 250 : F1098 – 106. | en_US |
dc.identifier.citedreference | Schetz M. Vasopressors and the kidney. Blood Purif 2002 ; 20 : 243 – 51. | en_US |
dc.identifier.citedreference | Vincent JL, De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 2005 ; 9 : S9 – 12. | en_US |
dc.identifier.citedreference | Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004 ; 32 : 1825 – 31. | en_US |
dc.identifier.citedreference | Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M for the Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2000 ; 345 : 1368 – 77. | en_US |
dc.identifier.citedreference | Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001 ; 345 : 1359 – 67. | en_US |
dc.identifier.citedreference | Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006 ; 354 : 449 – 61. | en_US |
dc.identifier.citedreference | Annane D, Sebille V, Charpentier C, Bollaert PE, FranÇois B, Korach JM, Capellier G, Cohen Y, Azoulay E, TrochÉ G, Chaumet-Riffaut P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002 ; 288 : 862 – 71. | en_US |
dc.identifier.citedreference | Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001 ; 344 : 699 – 709. | en_US |
dc.identifier.citedreference | Lin S-M, Huang C-D, Lin H-C, Liu C-Y, Wang CH, Kuo H-P. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock : a randomized controlled trial. Shock 2006 ; 26 : 551 – 7. | en_US |
dc.identifier.citedreference | Vincent JL, Angus D, Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G III, Bernard GR for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003 ; 31 : 834 – 40. | en_US |
dc.identifier.citedreference | Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002 ; 137 : 744 – 52. | en_US |
dc.identifier.citedreference | Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1) : a novel biomarker for human renal proximal tubule injury. Kidney Int 2002 ; 62 : 237 – 44. | en_US |
dc.identifier.citedreference | Du Cheyron D, Daubin C, Poggioli J, Ramakers M, Houillier P, Charbonneau P, Paillard M. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 2003 ; 42 : 497 – 506. | en_US |
dc.identifier.citedreference | Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005 ; 365 : 231 – 8. | en_US |
dc.identifier.citedreference | Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006 ; 70 : 199 – 203. | en_US |
dc.identifier.citedreference | Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM for the Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004 ; 32 : 858 – 73. | en_US |
dc.identifier.citedreference | Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A. The APACHE III Prognostic System. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991 ; 100 : 1619 – 36. | en_US |
dc.identifier.citedreference | Vincent JL, Moreno R, Takala J, Willatts S, De MendonÇa A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996 ; 22 : 707 – 10. | en_US |
dc.identifier.citedreference | Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007 ; 109 : 3161 – 72. | en_US |
dc.identifier.citedreference | Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, Laszik Z, Kosanke S, Peer G, Esmon CT. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 2000 ; 95 : 1680 – 6. | en_US |
dc.identifier.citedreference | Iba T, Kidokoro A, Fukunaga M, Nagakari K, Shirahama A, Ida Y. Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med 2005 ; 33 : 368 – 72. | en_US |
dc.identifier.citedreference | Levi M, Choi G, Schoots I, Schultz M, van der Poll T. Beyond sepsis : activated protein C and ischemia-reperfusion injury. Crit Care Med 2004 ; 32 ( Suppl. 5 ) : 309 – 12. | en_US |
dc.identifier.citedreference | Gupta A, Berg DT, Gerlitz B, Sharma GR, Syed S, Richardson MA, Sandusky G, Heuer JG, Galbreath EJ, Grinnell BW. Role of protein C in renal dysfunction after polymicrobial sepsis. J Am Soc Nephrol 2007 ; 18 : 860 – 7. | en_US |
dc.identifier.citedreference | Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal iNOS and angiotensin 2. Am J Physiol Renal Physiol 2007 ; 293 : F245 – 54. | en_US |
dc.identifier.citedreference | De Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent JL. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006 ; 34 : 1918 – 24. | en_US |
dc.identifier.citedreference | de MendonÇa A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F. Acute renal failure in the ICU : risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000 ; 26 : 915 – 21. | en_US |
dc.identifier.citedreference | Carbonell N, Blasco M, Ferreres J, Blanquer J, GarcÍa-RamÓn R, Mesejo A, Miguel A. Sepsis and SOFA score : related outcome for critically ill renal patients. Clin Nephrol 2004 ; 62 : 185 – 92. | en_US |
dc.identifier.citedreference | Bagshaw SM, Langenberg C, Wan L, May CN, Bellomo R. A systematic review of urinary findings in experimental septic acute renal failure. Crit Care Med 2007 ; 35 : 1592 – 8. | en_US |
dc.identifier.citedreference | Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002 ; 62 : 2223 – 9. | en_US |
dc.identifier.citedreference | Marotto MS, Marotto PC, Sztajnbok J, Seguro AC. Outcome of acute renal failure in meningococcemia. Ren Fail 1997 ; 19 : 807 – 10. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.